MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications

Satyanarayana Rachagani1, Sushil Kumar, Surinder K Batra

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Cancer Letters
|December 17, 2009
PubMed

Insights

MicroRNAs (miRNAs) play a role in pancreatic cancer. This review covers their function in cancer development, diagnosis, and potential therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression in mammals.
  • Aberrant miRNA expression is linked to various cancers, influencing pathogenesis, apoptosis, and cell growth.
  • miRNAs can act as tumor suppressors or oncogenes, impacting cancer development.

Purpose of the Study:

  • To review the current understanding of microRNAs in pancreatic cancer.
  • To discuss the role of miRNAs in pancreatic cancer development and progression.
  • To explore the diagnostic and therapeutic potential of miRNAs in pancreatic cancer.

Main Methods:

  • Literature review of recent studies on miRNAs in pancreatic cancer.
  • Analysis of miRNA involvement in cancer pathogenesis, cell growth, and apoptosis.
  • Synthesis of information regarding miRNA's diagnostic and prognostic value.

Main Results:

  • miRNA deregulation is implicated in tumor development and progression.
  • Altered miRNA expression is observed in various human malignancies.
  • miRNAs show potential as biomarkers for cancer diagnosis and prognosis.

Conclusions:

  • MicroRNAs are significant players in pancreatic cancer.
  • miRNA-based diagnostics and therapeutics are promising avenues for research.
  • Further investigation into miRNA functions can advance pancreatic cancer management.